Goodsurance

Policy & oversight

Medicare Hospice Rule Reveals 2 Billion Dollars in Parallel Medicare Billing During Patients' Hospice Elections

A CMS final rule published July 30 shows that nearly half of Medicare hospice patients also have conventional Medicare claims filed on their behalf during enrollment, totaling 2 billion dollars in FY 2025, and details how a nine-factor scoring index will flag outlier providers.

By the Goodsurance editorial teamJuly 29, 2026

The FY 2027 Hospice Wage Index and Payment Rate Update Final Rule, published July 30, 2026 by the Centers for Medicare and Medicaid Services, carries a data disclosure that goes well beyond rate-setting. According to the rule, almost half of all Medicare beneficiaries who elect hospice care also have non-hospice services billed to Medicare on their behalf during the same enrollment period. In fiscal year 2025, those non-hospice bills totaled 2.0 billion dollars, a 160 percent increase from fiscal year 2020.

Hospice is designed as a comprehensive end-of-life benefit: when a beneficiary enrolls, the hospice is generally responsible for all care related to the terminal diagnosis, and Medicare's regular fee-for-service program covers only unrelated conditions. The 2.0 billion dollar figure suggests that the boundary between what belongs to the hospice and what can be separately billed remains contested in practice.

To help identify providers with patterns worth scrutiny, CMS maintains the Service and Spending Variation Index (SSVI), a composite score drawn from nine claims-based measures. The SSVI tracks metrics including total non-hospice spending, the share of beneficiaries with stays exceeding 180 days, average minutes of care per routine home care day, and the rate of live discharges returning to the same hospice within seven days. Hospices with elevated SSVI scores are flagged for possible targeted education or program integrity review.

The FY 2027 rule updated provider-level SSVI data using FY 2024 and FY 2025 claims, making the scores available for public reference. CMS also finalized a requirement that hospices provide an addendum to each beneficiary's election statement, describing items, services, and drugs related to the terminal illness that the hospice will not cover. The annual payment cap per hospice for FY 2027 is set at 36,174.75 dollars, a 2.3 percent increase from the FY 2026 figure.

For beneficiaries or family members choosing a hospice agency, the SSVI data is publicly available through CMS and may support a more informed comparison of providers.

In plain words

Medicare pays for hospice care when a patient is near the end of life. The hospice is supposed to handle most of the patient's care. But about half of all patients in hospice also have other Medicare bills filed in their name at the same time. In 2025 alone, those extra bills came to 2 billion dollars. CMS keeps a score for every hospice agency that shows how much extra billing and unusual care patterns appear at that location. In 2027, hospices must also give patients a written list explaining what services the hospice will not cover. CMS can use this scoring tool to find agencies that may need a closer look.

Source: CMS
Read at the source →

More news

Other stories on what is moving in Medicare.

Policy & oversight

OIG Found More Than 15 Million Dollars in Medicare Payments Where Emergency Room Billing Codes Were Used at Non-Emergency Sites

A March 2026 federal audit identified improper and potentially improper Medicare payments made when physicians and hospitals used emergency department billing codes for care not actually delivered in an emergency department, and found that Medicare lacked automated safeguards to catch the mismatches.

August 8, 2026

Policy & oversight

Federal Audit Found at Least 4.7 Million Dollars in Medicare Overpayments at an Arkansas Hospital

An OIG audit of Jefferson Regional Medical Center found a high rate of billing errors on claims flagged as elevated risk, producing an estimated 4.7 million dollars in improper Medicare payments. The hospital disputed most of the findings.

August 7, 2026

Policy & oversight

CMS Publishes Plan to Speed Medicare Coverage for Breakthrough Medical Devices

A new pathway would give FDA-cleared breakthrough devices a national Medicare coverage decision within weeks of regulatory approval, rather than waiting years under the standard process.

August 7, 2026

Policy & oversight

Federal Audit Found 97 Cybersecurity Gaps in Medicare Billing Contractors for Fiscal Year 2024, Though the Most Serious Deficiencies Declined

An OIG annual report to Congress found information security deficiencies across all seven Medicare administrative contractors in fiscal year 2024, while noting that high-risk and moderate-risk gaps fell compared with the prior year.

August 6, 2026

Policy & oversight

CMS Published Second-Quarter 2026 Drug Coding Decisions That Shape How Medicare Identifies and Pays for New Medicines

The quarterly HCPCS drug coding update, posted July 29 and highlighted in the August 6 MLN Connects newsletter, determines which new medications and biologicals get a dedicated Medicare billing code.

August 6, 2026

Policy & oversight

CMS Sets a Sunset Date for the NTAP Alternative Track for Breakthrough Devices and Advances the RAPID Pathway

The fiscal year 2027 hospital payment final rule phases out the alternative NTAP track that breakthrough-designated devices used to qualify for Medicare reimbursement, while a new CMS-FDA program called RAPID is positioned to take its place.

August 5, 2026